232 related articles for article (PubMed ID: 30518842)
21. AURKB promotes gastric cancer progression via activation of
Nie M; Wang Y; Yu Z; Li X; Deng Y; Wang Y; Yang D; Li Q; Zeng X; Ju J; Liu M; Zhao Q
Aging (Albany NY); 2020 Jan; 12(2):1304-1321. PubMed ID: 31982864
[TBL] [Abstract][Full Text] [Related]
22. CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes.
Lu D; Wu Y; Wang Y; Ren F; Wang D; Su F; Zhang Y; Yang X; Jin G; Hao X; He D; Zhai Y; Irwin DM; Hu J; Sung JJ; Yu J; Jia B; Chang Z
Cancer Cell; 2012 Jan; 21(1):92-104. PubMed ID: 22264791
[TBL] [Abstract][Full Text] [Related]
23. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1.
Liu F; Li X; Wang C; Cai X; Du Z; Xu H; Li F
Int J Cancer; 2009 Dec; 125(11):2511-9. PubMed ID: 19610058
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.
Jia Y; Yan Q; Zheng Y; Li L; Zhang B; Chang Z; Wang Z; Tang H; Qin Y; Guan XY
J Exp Clin Cancer Res; 2022 Sep; 41(1):287. PubMed ID: 36171622
[TBL] [Abstract][Full Text] [Related]
26. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer.
Zheng G; Li W; Zuo B; Guo Z; Xi W; Wei M; Chen P; Wen W; Yang AG
Biochem Biophys Res Commun; 2016 Nov; 480(3):436-442. PubMed ID: 27773816
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication.
Begnami MD; Fregnani JH; Nonogaki S; Soares FA
Hum Pathol; 2010 Aug; 41(8):1120-7. PubMed ID: 20334896
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer.
Xu X; Li W; Fan X; Liang Y; Zhao M; Zhang J; Liang Y; Tong W; Wang J; Yang W; Lu Y
Oncogene; 2007 Nov; 26(52):7371-9. PubMed ID: 17525738
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
[TBL] [Abstract][Full Text] [Related]
30. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
Zhang Z; Shao L; Wang Y; Luo X
Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
[TBL] [Abstract][Full Text] [Related]
32. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
Li M; Liu H; Zhao Q; Han S; Zhou L; Liu W; Li W; Gao F
Cell Death Dis; 2021 Feb; 12(2):152. PubMed ID: 33542222
[TBL] [Abstract][Full Text] [Related]
33. PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.
Huang L; Peng Y; Zhong G; Xie W; Dong W; Wang B; Chen X; Gu P; He W; Wu S; Lin T; Huang J
Oncotarget; 2015 Jun; 6(18):16366-78. PubMed ID: 25978027
[TBL] [Abstract][Full Text] [Related]
34. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
35. CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage.
Cazales M; Schmitt E; Montembault E; Dozier C; Prigent C; Ducommun B
Cell Cycle; 2005 Sep; 4(9):1233-8. PubMed ID: 16082213
[TBL] [Abstract][Full Text] [Related]
36. ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.
Shi Q; Wang W; Jia Z; Chen P; Ma K; Zhou C
Oncotarget; 2016 Jun; 7(24):36489-36500. PubMed ID: 27183908
[TBL] [Abstract][Full Text] [Related]
37. The kinetics of G2 and M transitions regulated by B cyclins.
Huang Y; Sramkoski RM; Jacobberger JW
PLoS One; 2013; 8(12):e80861. PubMed ID: 24324638
[TBL] [Abstract][Full Text] [Related]
38. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of SASS6 reduces growth of MDA‑MB‑231 triple‑negative breast cancer cells through arrest of the cell cycle at the G2/M phase.
Du L; Jing J; Wang Y; Xu X; Sun T; Shi Y; Wang W; Tian B; Han C; Zhao X; Chang H
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907854
[TBL] [Abstract][Full Text] [Related]
40. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
